EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation

Xiaozhe Li, Meilan Chen, Lifen Kuang, Junru Liu iD, Beihui Huang, Juan Li iD

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 10.05.2026. Verfasst von Xiaozhe Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Neoplasm, Residual, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Municipal Science and Technology Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Minimal residual disease (MRD) testing is essential for evaluating treatment response among multiple myeloma (MM) patients. Many patients experience MRD progression (MRD‐P) before they meet the criteria for clinical or biochemical progression (PD), thus raising questions about the timing of treatment. In this retrospective study, the effect of early intervention (EI) on prognosis was investigated among 42 newly diagnosed MM patients who developed MRD‐P after initial treatment with autologous stem cell transplantation. In the EI group ( n = 9), treatment was modified at the onset of MRD‐P; in the PD group ( n = 33), treatment was delayed until disease progression occurred. At a median follow‐up of 25 months, compared with the PD group, the EI group demonstrated a longer time to progression (median 34.8 months vs. 6.6 months, p = 0.029), superior overall survival (median not reached vs. 41.0 months, p = 0.034), and significantly higher MRD re‐negativity rates (median 12.6 months vs. 75.9 months, p < 0.001). Multivariate analysis revealed that early intervention was significantly associated with improved MRD re‐negativity (HR = 0.07; p = 0.001). This hypothesis‐generating retrospective study demonstrated that early intervention at MRD‐P onset was associated with improved survival outcomes and higher rates of MRD re‐negativity in this cohort. Despite significant limitations, such as the small sample size, nonrandomized design, and unmeasured confounders, these findings provide preliminary data to inform the design of future prospective randomized trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaNeoplasm, ResidualHematopoietic Stem Cell TransplantationHumansDisease ProgressionFemaleTransplantation, AutologousRetrospective StudiesMaleMiddle AgedPrognosisAdultAgedTreatment Outcome

Stichwörter der Autor:innen

MRD progressionautologous stem cell transplantation (ASCT)early interventionminimal residual disease (MRD)multiple myeloma (MM)

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.

ORCID-Profile: Junru Liu, Juan Li

Förderung

  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Chen, M., Kuang, L., Liu, J., Huang, B., & Li, J. (2026). Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71911

Vancouver

Li X, Chen M, Kuang L, Liu J, Huang B, Li J. Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71911

BibTeX
@article{Li2026,
  author = {Li, Xiaozhe and Chen, Meilan and Kuang, Lifen and Liu, Junru and Huang, Beihui and Li, Juan},
  title = {Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71911}
}
Kostenlos starten →